What was checked
New study reports Fenbendazole linked to remission or near-remission in THREE Stage IV Cancer Patients (breast, prostate, melanoma) with dramatic tumor regression and long-lasting remission without chemotherapy. Clinical trials should be urgently initiated.
Assessment summary
Needs cautionThe case series reported sustained outcomes and no chemotherapy, but patients received other treatments such as hormone therapy, radiation, surgery, supplements, or androgen-deprivation therapy. These uncontrolled cases cannot show that fenbendazole caused tumor regression or remission. This is a recommendation rather than a directly testable fact. Fenbendazole may warrant properly designed research, but available sources do not establish an urgent clinical need or demonstrated effectiveness in humans; experts report insufficient evidence of safety and efficacy. (Only 1 of 3 AI systems responded.)